Chlorpromazine (Teva-Chlorpromazine)
Phenothiazine antipsychotic / antiemetic
Chlorpromazine (Teva-Chlorpromazine)
Forms and strengths
Form: TabletStrength: 25 mg, 50 mg, 100 mg
References
Indication
- Chlorpromazine is used to manage psychotic disorders such as schizophrenia.
- Chlorpromazine is used to prevent and treat nausea and vomiting when other, safer antiemetic agents are ineffective or unavailable.
- Chlorpromazine is not indicated for use in elderly patients with dementia-related psychosis.
Pregnancy
- Chlorpromazine and its metabolites cross the placental barrier, so it should not be used during pregnancy unless the expected benefit to the mother clearly outweighs the potential risk to the fetus.
- Most studies suggest phenothiazines are not strongly teratogenic, but there are reports of malformations in infants exposed during the first trimester, so chlorpromazine should be used cautiously in women of childbearing potential or during early pregnancy.
- Babies exposed to chlorpromazine during the third trimester may experience withdrawal-type symptoms after birth, including agitation, muscle tone changes, tremor, difficulty breathing, feeding problems, and jaundice, ranging from mild and self-limited to requiring intensive care.
Breastfeeding
- Chlorpromazine and its metabolites pass into breast milk, so it should be used with caution during breastfeeding because of possible sedative and anticholinergic effects in the nursing infant.
Geriatrics
- Chlorpromazine is not indicated for elderly patients with dementia, since antipsychotic drugs in this population carry an increased risk of death, largely from cardiovascular or infectious causes.
- Safety and efficacy of chlorpromazine have not been specifically studied in patients 65 and older; a reduced dose is generally recommended in this age group.
- Older adults are more susceptible to chlorpromazine's effects on cardiovascular conditions and to orthostatic hypotension, so blood pressure should be monitored closely.
Pediatrics
- The safety and efficacy of chlorpromazine in children and adolescents under 18 have not been studied, so its use is not recommended in this age group.
- Chlorpromazine should be avoided in children or adolescents with signs suggestive of Reye's syndrome, since its effects can mask or mimic the condition.
Dosage & Administration
- For psychotic disorders in adults, treatment usually starts at 25 to 75 mg daily in 2 to 4 divided doses, or as a single 75 mg dose at bedtime.
- The daily dose for psychotic disorders may be increased twice weekly by 25 to 50 mg until symptoms are controlled, up to a maximum recommended dose of 1 g per day.
- Once symptoms are controlled, the dose should be reduced to the lowest amount that maintains symptom relief, often given once or twice daily with the largest dose at bedtime.
- For nausea and vomiting in adults, the starting dose is 12.5 to 25 mg every 4 to 6 hours, increased as needed and tolerated, up to a maximum of 150 mg per day.
- Dosage should be started low and increased gradually, with lower doses generally used in elderly or debilitated patients and in first-episode psychosis.
- If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose, in which case the missed dose should be skipped; doses should never be doubled.
- Tablets should be swallowed whole with a full glass of water and should not be chewed, dissolved, or crushed.
Overdose
If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.
- Overdose can cause parkinsonism-like movement effects and acute dystonic reactions (sudden, sustained muscle contractions).
- Central nervous system effects can include drowsiness and seizures.
- Anticholinergic effects such as dry mouth, blurred vision, and urinary retention may occur.
- Cardiovascular effects can include rapid heart rate, abnormal heart rhythms, and low blood pressure.
- Body temperature regulation may be disrupted, causing either an abnormally low or high temperature.
- Low blood pressure is treated with intravenous fluids and positioning the patient with the legs elevated; dopamine may be used if this is not effective.
- If a vasopressor drug is needed, alpha-agonists such as phenylephrine are preferred, since epinephrine can worsen the drop in blood pressure.
- Seizures are treated with intravenous diazepam, and acute dystonic reactions are treated with intravenous diphenhydramine, benztropine, or trihexyphenidyl.
- Hemodialysis does not effectively remove chlorpromazine from the body, but hemoperfusion may help in severe cases.
Common side effects
- Dry mouth may occur.
- Drowsiness may occur.
- Dizziness may occur.
- Nasal congestion may occur.
- Nausea and vomiting may occur, paradoxically, in some patients.
- Headache may occur.
- Blurred vision may occur.
- Urinary incontinence may occur.
- Weight changes may occur.
- Menstrual changes and altered libido may occur.
- Breast swelling and unexpected milk production, in both men and women, may occur.
- Increased sweating may occur.
- Constipation may occur and can become severe; tell your doctor if it occurs or worsens.
Serious side effects
Serious side effects require immediate discussion with the prescriber or emergency care.
- Neuroleptic malignant syndrome, a rare but potentially fatal reaction with high fever, muscle rigidity, rapid heartbeat, and confusion, may occur.
- Tardive dyskinesia, a movement disorder causing involuntary movements of the tongue, face, or body that may be persistent or irreversible, may develop, especially with long-term use.
- Extrapyramidal symptoms, including muscle stiffness, tremor, drooling, and abnormal eye movements, may occur.
- Akathisia, an inner sense of restlessness with an inability to stay still, may occur.
- Seizures or fits may occur, since chlorpromazine can lower the seizure threshold.
- Serious blood disorders, including agranulocytosis, leukopenia, and aplastic anemia, may occur, most often between the fourth and tenth week of treatment.
- Jaundice, yellowing of the skin or eyes, and other liver problems may occur.
- Severe allergic reactions, including swelling of the face, lips, tongue, or throat and difficulty breathing, may occur.
- Blood clots, which can cause swelling, pain, and redness in an arm or leg and can lead to chest pain or difficulty breathing if they travel to the lungs, may occur.
- Fast or irregular heartbeat may occur.
- Severe low blood pressure, with lightheadedness or fainting especially when standing up, may occur.
- High blood sugar or diabetic ketoacidosis may occur, even in patients with no prior history of blood sugar problems.
- Long-lasting, painful erection (priapism) may occur rarely.
- Abnormal pigmentation of the skin or eyes may occur with long-term, high-dose treatment; periodic eye examinations are recommended in these patients.
- Retinopathy, damage to the retina, has been associated with phenothiazine use.
- Fatal hyperthermia and heat stroke are possible, since chlorpromazine can impair the body's ability to regulate temperature.
- Seek immediate medical attention for high fever with muscle stiffness, uncontrollable movements, signs of a blood clot, severe allergic reaction, or a fast or irregular heartbeat.
Use with caution
- Use with caution in patients with cardiovascular disease, since chlorpromazine can cause low blood pressure and changes in heart rhythm, including QT interval prolongation.
- Use with caution in elderly or alcohol-dependent patients, who are more prone to orthostatic hypotension.
- Use with caution in patients with a history of seizures, since chlorpromazine can lower the seizure threshold.
- Use with caution in patients performing hazardous tasks such as driving or operating machinery, since chlorpromazine can cause drowsiness, especially early in treatment.
- Use with caution in patients with diabetes or risk factors for high blood sugar, and monitor blood glucose and weight periodically.
- Use with caution in patients at risk of intestinal obstruction, since chlorpromazine's anticholinergic effects can mask or worsen this condition.
- Use with caution regarding sun exposure, since chlorpromazine can cause photosensitivity; sunscreen and protective clothing are recommended.
- Use with caution in hot environments or during exercise, since chlorpromazine can impair temperature regulation and increase heat stroke risk.
- Abrupt discontinuation after high-dose therapy may cause withdrawal-like symptoms such as gastritis, nausea, vomiting, dizziness, and tremor; do not stop treatment suddenly without medical guidance.
- Baseline and periodic blood counts should be monitored throughout treatment because of the risk of blood cell disorders.
- Use with caution in patients with risk factors for blood clots, such as older age, obesity, smoking, recent major surgery, prolonged immobility, or oral contraceptive use.
Contraindications
- Contraindicated in patients hypersensitive to chlorpromazine, other phenothiazines, or any ingredient in the tablet.
- Contraindicated in comatose states or in patients with severe central nervous system depression caused by other CNS depressant drugs.
- Contraindicated in patients with blood dyscrasias, blood cell disorders.
- Contraindicated in patients with bone marrow depression.
- Contraindicated in patients with liver damage.
- Contraindicated in patients with pheochromocytoma, a tumour of the adrenal gland.
- Contraindicated in patients scheduled for spinal or regional anesthesia.
- Should be avoided in children or adolescents with signs or symptoms suggestive of Reye's syndrome, since chlorpromazine's antiemetic and CNS effects can mask or be confused with the signs of Reye's syndrome or other encephalopathies.
Drug interactions
- Alcohol, barbiturates, and other sedatives can intensify chlorpromazine's central nervous system depressant effects and may cause respiratory depression.
- Chlorpromazine can exaggerate the blood-pressure-lowering effect of most antihypertensive drugs, especially alpha-adrenergic blockers.
- Other anticholinergic drugs may enhance chlorpromazine's mild anticholinergic effects, while anticholinergic drugs may reduce chlorpromazine's antipsychotic effect.
- Chlorpromazine may oppose the action of amphetamine, levodopa, epinephrine, clonidine, and guanethidine.
- At high doses, chlorpromazine can blunt the response to medications used to lower blood sugar, potentially requiring a dose increase of the diabetes medication.
- Chlorpromazine may interact with cabergoline, guanadrel, metrizamide, sparfloxacin, cisapride, and antihistamines.
- Lithium combined with chlorpromazine may increase the risk of neurological side effects.
- Phenothiazines such as chlorpromazine may cause false-positive results on urine phenylketonuria test results.
- Chlorpromazine can increase the toxicity of organophosphate insecticides, including agricultural, veterinary, and household pest-control products.
Food interactions
- Avoid alcohol while taking chlorpromazine, as it can add to the drug's sedative effects.
- No other specific food interactions have been established for chlorpromazine.
Time of administration
- Chlorpromazine tablets can be taken with or without food, but should be taken with a full glass of water.
- For psychiatric use, the tablets are often taken at the same time each day, with the largest maintenance dose typically given at bedtime to take advantage of its sedative effect.
- For nausea and vomiting, doses are typically spaced every 4 to 6 hours as needed rather than tied to a specific time of day.
Storage
- Store chlorpromazine tablets between 15°C and 25°C, out of the reach and sight of children.
Patient take-away
- Chlorpromazine is an effective antipsychotic and antiemetic, but it requires regular blood monitoring, careful dose titration, and awareness of serious risks like neuroleptic malignant syndrome and tardive dyskinesia; never stop it abruptly, and seek urgent care for high fever, muscle rigidity, uncontrollable movements, or signs of an allergic reaction.